JAMA Network
About The Study: The findings of this study that included 43,000 veterans suggest that Black veterans hospitalized with COVID-19 were less likely to be treated with evidence-based COVID-19 treatments, including systemic steroids, remdesivir, and immunomodulatory drugs. Differences in care were partially explained by within- and between-hospital differences and underscore the need for a comprehension approach to minimize racial variation in COVID-19 care.
Authors: Florian B. Mayr, M.D., M.P.H., of the VA Pittsburgh Healthcare System in Pittsburgh, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2022.38507)
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
